Factors Associated with Loss to Follow-up during Treatment for Multidrug-Resistant Tuberculosis, the Philippines, 2012-2014.

Emerging Infectious Diseases
Thelma E TupasiJesus N Sarol

Abstract

To identify factors associated with loss to follow-up during treatment for multidrug-resistant (MDR) tuberculosis (TB) in the Philippines, we conducted a case-control study of adult patients who began receiving treatment for rifampin-resistant TB during July 1-December 31, 2012. Among 91 case-patients (those lost to follow-up) and 182 control-patients (those who adhered to treatment), independent factors associated with loss to follow-up included patients' higher self-rating of the severity of vomiting as an adverse drug reaction and alcohol abuse. Protective factors included receiving any type of assistance from the TB program, better TB knowledge, and higher levels of trust in and support from physicians and nurses. These results provide insights for designing interventions aimed at reducing patient loss to follow-up during treatment for MDR TB.

References

Jan 24, 2009·Social Science & Medicine·Yin-Yang Lee, Julia L Lin
Feb 28, 2009·The Lancet Infectious Diseases·Evan W OrensteinAlison P Galvani
Nov 11, 2011·PharmacoEconomics·Christopher Fitzpatrick, Katherine Floyd
Jan 24, 2012·Health Education & Behavior : the Official Publication of the Society for Public Health Education·Shelley D Golden, Jo Anne L Earp
May 16, 2012·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·M T GlerT E Tupasi
Sep 7, 2012·PLoS Medicine·Shama D AhujaUNKNOWN Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB
Dec 6, 2012·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·A ToczekN Ford
Mar 16, 2013·Addiction·Sonya ShinUNKNOWN Tomsk Tuberculosis Alcohol Working Group
Feb 14, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Geetha Ramachandran, Soumya Swaminathan
Oct 29, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J Peter CegielskiUNKNOWN Global PETTS Investigators

❮ Previous
Next ❯

Citations

Dec 16, 2016·Tropical Medicine & International Health : TM & IH·Kefyalew Addis AleneArchie C A Clements
Aug 6, 2017·Infection·Nathan KapataFrank Cobelens
Feb 3, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ming-Chih YuYi-Wen Huang
Jul 31, 2019·The International Journal of Health Planning and Management·RegineYnez H De MesaAntonio Miguel L Dans
Jul 25, 2019·The American Journal of Tropical Medicine and Hygiene·María Luisa AznarIsrael Molina Romero
Jun 20, 2020·Transactions of the Royal Society of Tropical Medicine and Hygiene·Muhammad AtifSajjad Sarwar
May 11, 2019·The European Respiratory Journal·Ian F WalkerJames N Newell
Mar 21, 2019·Tuberculosis Research and Treatment·Tamary Henry LeveriKajiru Kilonzo
May 1, 2021·International Journal of Environmental Research and Public Health·Hafte Kahsay KebedePaul Ward
Jun 26, 2021·Revista Panamericana De Salud Pública = Pan American Journal of Public Health·Gloria Mercedes Puerto CastroFreddy Pérez
Oct 11, 2021·BMC Infectious Diseases·Patricia BartholomayWildo Navegantes de Araújo

❮ Previous
Next ❯

Software Mentioned

Access
SAS
Excel

Related Concepts

Related Feeds

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Related Papers

Addictive Diseases
R M Zarco, M P Almonte
Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica
B V Reyes
© 2022 Meta ULC. All rights reserved